Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

·24 Aug
Share:PostShare

– Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026

G

Globe Newswire

Original source

Read full story

access us

Check live status on DownRightNow

Check status →

Related Stories

Health4h ago

Recover Like Josh Allen

The quarterback knows that recuperation is as important as your training regime. Here’s how he does it.

MMen's Health

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer